591 related articles for article (PubMed ID: 31584111)
1. Animal models of major depression: drawbacks and challenges.
Planchez B; Surget A; Belzung C
J Neural Transm (Vienna); 2019 Nov; 126(11):1383-1408. PubMed ID: 31584111
[TBL] [Abstract][Full Text] [Related]
2. Rodent models of treatment-resistant depression.
Caldarone BJ; Zachariou V; King SL
Eur J Pharmacol; 2015 Apr; 753():51-65. PubMed ID: 25460020
[TBL] [Abstract][Full Text] [Related]
3. Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression I: bio-behavioural validation and response to imipramine.
Brand SJ; Harvey BH
Acta Neuropsychiatr; 2017 Aug; 29(4):193-206. PubMed ID: 27573792
[TBL] [Abstract][Full Text] [Related]
4. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
Cerbo AD
Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
[TBL] [Abstract][Full Text] [Related]
5. Treatment-resistant depression: are animal models of depression fit for purpose?
Willner P; Belzung C
Psychopharmacology (Berl); 2015 Oct; 232(19):3473-95. PubMed ID: 26289353
[TBL] [Abstract][Full Text] [Related]
6. The recent progress in animal models of depression.
Wang Q; Timberlake MA; Prall K; Dwivedi Y
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():99-109. PubMed ID: 28396255
[TBL] [Abstract][Full Text] [Related]
7. Prelimbic Stimulation Ameliorates Depressive-Like Behaviors and Increases Regional BDNF Expression in a Novel Drug-Resistant Animal Model of Depression.
Moshe H; Gal R; Barnea-Ygael N; Gulevsky T; Alyagon U; Zangen A
Brain Stimul; 2016; 9(2):243-50. PubMed ID: 26655599
[TBL] [Abstract][Full Text] [Related]
8. The HDAC inhibitor SAHA improves depressive-like behavior of CRTC1-deficient mice: Possible relevance for treatment-resistant depression.
Meylan EM; Halfon O; Magistretti PJ; Cardinaux JR
Neuropharmacology; 2016 Aug; 107():111-121. PubMed ID: 26970016
[TBL] [Abstract][Full Text] [Related]
9. Rapid antidepressant effects of deep brain stimulation of the pre-frontal cortex in an animal model of treatment-resistant depression.
Papp M; Gruca P; Lason M; Tota-Glowczyk K; Niemczyk M; Litwa E; Willner P
J Psychopharmacol; 2018 Oct; 32(10):1133-1140. PubMed ID: 30182787
[TBL] [Abstract][Full Text] [Related]
10. Understanding the genetic aspects of resistance to antidepressants treatment.
Alqahtani AM; Kumarappan C; Kumar V; Srinivasan R; Krishnaraju V
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7784-7795. PubMed ID: 32744705
[TBL] [Abstract][Full Text] [Related]
11. [Peripheral prognostic biomarkers of response in treatment-resistant depression].
Agorastos A; Gkesoglou T; Kleidonopoulos A; Bozikas VP
Psychiatriki; 2021 Dec; 32(Supplement I):44-54. PubMed ID: 34990379
[TBL] [Abstract][Full Text] [Related]
12. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
[TBL] [Abstract][Full Text] [Related]
13. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
[TBL] [Abstract][Full Text] [Related]
14. Animal models of major depression and their clinical implications.
Czéh B; Fuchs E; Wiborg O; Simon M
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():293-310. PubMed ID: 25891248
[TBL] [Abstract][Full Text] [Related]
15. A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients.
Li G; Zhang L; DiBernardo A; Wang G; Sheehan JJ; Lee K; Reutfors J; Zhang Q
PLoS One; 2020; 15(9):e0238843. PubMed ID: 32915863
[TBL] [Abstract][Full Text] [Related]
16. Open questions in current models of antidepressant action.
Tanti A; Belzung C
Br J Pharmacol; 2010 Mar; 159(6):1187-200. PubMed ID: 20132212
[TBL] [Abstract][Full Text] [Related]
17. Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition.
Hidalgo-Mazzei D; Berk M; Cipriani A; Cleare AJ; Florio AD; Dietch D; Geddes JR; Goodwin GM; Grunze H; Hayes JF; Jones I; Kasper S; Macritchie K; McAllister-Williams RH; Morriss R; Nayrouz S; Pappa S; Soares JC; Smith DJ; Suppes T; Talbot P; Vieta E; Watson S; Yatham LN; Young AH; Stokes PRA
Br J Psychiatry; 2019 Jan; 214(1):27-35. PubMed ID: 30520709
[TBL] [Abstract][Full Text] [Related]
18. BDNF Alterations in Brain Areas and the Neurocircuitry Involved in the Antidepressant Effects of Ketamine in Animal Models, Suggest the Existence of a Primary Circuit of Depression.
Carboni E; Carta AR
J Integr Neurosci; 2022 Aug; 21(5):144. PubMed ID: 36137960
[TBL] [Abstract][Full Text] [Related]
19. The Wistar-Kyoto rat model of endogenous depression: A tool for exploring treatment resistance with an urgent need to focus on sex differences.
Millard SJ; Weston-Green K; Newell KA
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109908. PubMed ID: 32145362
[TBL] [Abstract][Full Text] [Related]
20. Gene expression signature of antidepressant treatment response/non-response in Flinders Sensitive Line rats subjected to maternal separation.
Marchetti L; Lauria M; Caberlotto L; Musazzi L; Popoli M; Mathé AA; Domenici E; Carboni L
Eur Neuropsychopharmacol; 2020 Feb; 31():69-85. PubMed ID: 31813757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
